Insmed Incorporated (0JAV.L)
USD 71.8
(-4.53%)
USD 71.8
(-4.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 305.2 Million | 245.35 Million | 188.46 Million | 164.41 Million | 136.46 Million | 9.83 Million |
| Cost of Revenue | 65.57 Million | 55.12 Million | 44.15 Million | 39.87 Million | 24.21 Million | 2.42 Million |
| Gross Profit | 239.63 Million | 190.23 Million | 144.3 Million | 124.54 Million | 112.25 Million | 7.41 Million |
| Operating Expenses | 949.26 Million | 668.35 Million | 512.06 Million | 389.77 Million | 347.5 Million | 314.75 Million |
| Selling, General and Administrative Expenses | 344.5 Million | 265.78 Million | 234.27 Million | 203.61 Million | 210.79 Million | 168.21 Million |
| Research and Development Expenses | 571.01 Million | 397.51 Million | 272.74 Million | 181.15 Million | 131.71 Million | 145.28 Million |
| Other Expenses | 33.74 Million | 5.05 Million | 5.05 Million | 5 Million | 4.99 Million | 602 Thousand |
| Cost and Expenses | 1.01 Billion | 723.48 Million | 556.22 Million | 429.64 Million | 371.71 Million | 317.17 Million |
| Operating Income | -709.62 Million | -478.12 Million | -367.76 Million | -265.23 Million | -235.24 Million | -307.33 Million |
| Interest Expense | - | 26.44 Million | 40.47 Million | 29.56 Million | 27.7 Million | 25.47 Million |
| Income Tax Expense | 2.55 Million | 1.38 Million | -1.75 Million | 1.4 Million | 777 Thousand | 201 Thousand |
| Earnings before Tax | -747.01 Million | -480.15 Million | -436.41 Million | -292.68 Million | -253.56 Million | -324.07 Million |
| Net Income | -749.56 Million | -481.53 Million | -434.65 Million | -294.09 Million | -254.33 Million | -324.27 Million |
| Earnings Per Share Basic | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 | -4.22 |
| Earnings Per Share Diluted | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 | -4.22 |
| Weighted Average Shares Outstanding | 140.43 Million | 123.03 Million | 112.11 Million | 97.6 Million | 84.56 Million | 76.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 140.43 Million | 123.03 Million | 112.11 Million | 97.6 Million | 84.56 Million | 76.88 Million |
| Gross Margin | 0.79 | 0.78 | 0.77 | 0.76 | 0.82 | 0.75 |
| EBIT Margin | -2.15 | -1.87 | -1.98 | -1.58 | -1.69 | -31.06 |
| Profit Margin | -2.46 | -1.96 | -2.31 | -1.79 | -1.86 | -32.97 |
| EBITDA | -654.73 Million | -429.43 Million | -375.09 Million | -250.37 Million | -215.67 Million | -293.77 Million |
| Earnings Before Tax Margin | -2.33 | -1.95 | -1.95 | -1.61 | -1.72 | -31.25 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 93.42 Million | 90.34 Million | 75.5 Million | 305.2 Million | 83.69 Million | 79.07 Million |
| Cost of Revenue | 21.17 Million | 22.22 Million | 18.72 Million | 65.57 Million | 18.44 Million | 16.7 Million |
| Gross Profit | 72.25 Million | 68.11 Million | 56.78 Million | 239.63 Million | 65.25 Million | 62.36 Million |
| Operating Expenses | 285.68 Million | 253.31 Million | 214.18 Million | 920.56 Million | 227.82 Million | 201.03 Million |
| Selling, General and Administrative Expenses | 118.93 Million | 106.56 Million | 93.1 Million | - | 89.53 Million | 90.62 Million |
| Research and Development Expenses | 150.8 Million | 146.74 Million | 121.08 Million | - | 137.02 Million | 109.14 Million |
| Other Expenses | 15.94 Million | -269 Thousand | -1.1 Million | 1.85 Million | 2.17 Million | 285 Thousand |
| Cost and Expenses | 306.85 Million | 275.54 Million | 232.9 Million | 986.13 Million | 246.26 Million | 217.74 Million |
| Operating Income | -213.42 Million | -185.2 Million | -157.4 Million | -709.62 Million | -178.27 Million | -147.66 Million |
| Interest Expense | -21.05 Million | 20.17 Million | 19.94 Million | 76.25 Million | 19.82 Million | 19.11 Million |
| Income Tax Expense | 1.01 Million | 838 Thousand | 589 Thousand | 2.55 Million | 998 Thousand | 544 Thousand |
| Earnings before Tax | -219.51 Million | -299.77 Million | -156.5 Million | -747.01 Million | -185.06 Million | -158.38 Million |
| Net Income | -220.52 Million | -300.6 Million | -157.09 Million | -749.56 Million | -186.06 Million | -158.93 Million |
| Earnings Per Share Basic | -1.27 | -1.94 | -1.06 | - | -1.28 | -1.11 |
| Earnings Per Share Diluted | -1.27 | -1.94 | -1.06 | - | -1.28 | -1.11 |
| Weighted Average Shares Outstanding | 173.72 Million | 154.7 Million | 148.45 Million | 140.43 Million | 144.8 Million | 142.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 173.72 Million | 154.7 Million | 148.45 Million | 140.43 Million | 144.8 Million | 142.89 Million |
| Gross Margin | 0.77 | 0.75 | 0.75 | 0.79 | 0.78 | 0.79 |
| EBIT Margin | -2.28 | -2.02 | -2.05 | - | -1.90 | -1.73 |
| Profit Margin | -2.36 | -3.33 | -2.08 | -2.46 | -2.22 | -2.01 |
| EBITDA | -213.42 Million | -182.5 Million | -154.55 Million | - | -158.62 Million | -136.8 Million |
| Earnings Before Tax Margin | -2.28 | -2.05 | -2.08 | -2.33 | -2.13 | -1.87 |
WNBZ
PYRUM
JAYAGROGN
2302
SCOUT
STIM